← Leaderboards
Charles J Gauntt
Biomedical Development Corporation
$1,762,538
Attributed
$1,762,538
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $410.4K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$1,762,538 · 6
By mechanism
R44$1,055,051 · 1
R43$573,756 · 4
R41$133,731 · 1
Top collaborators
No co-investigators on record.
Most similar at Biomedical Development Corporation
Same institution · by research overlap
- Bakul M Bhatt$4,183,293
- Kenneth C Norbury$318,664
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularPublic Health Medicine (Field)EndotoxinsMicrobial BiofilmsPlayProfessorChronicDoctor Of PhilosophyIodineLeadPharmacologic SubstanceBacteriaBasePrincipal InvestigatorAntimicrobialChemical ReactionAcuteDesignEngineeringInflammatoryClinical ResearchClinical TrialsPathogenResearch Personnel
Grant awards (8)
Unique Anti-microbial Rinse to Reduce Oral Inflammation$299,915
R44 · FY2012 · HL · contact PI
Unique Anti-microbial Rinse to Reduce Oral Inflammation$410,355
R44 · FY2010 · HL · contact PI
Unique Anti-microbial Rinse to Reduce Oral Inflammation$344,781
R44 · FY2009 · HL · contact PI
Novel Therapy to Treat Otitis Media$107,000
R43 · FY2008 · HD · contact PI
Non-Toxic Gel to Treat Vulvovaginal Candidiasis$110,322
R43 · FY2006 · AI · contact PI
Novel Topical Treatment for Postherpetic Neuralgia$196,914
R43 · FY2005 · AR
Novel Rinse to Treat Oral Candidiasis in Cancer Patients$159,520
R43 · FY2005 · DE
Novel Skin Barrier to Prevent and Treat Poison Ivy$133,731
R41 · FY2004 · AR